Pharmaceutical Sifter
Pharmaceutical Sifter
What Is Pharmaceutical Sifter
A pharmaceutical sifter is a vibratory screening machine used to classify, de-lump, and remove oversize particles or foreign matter from powders and granules at critical stages of the oral solid dosage manufacturing process. By passing material through a precisely sized mesh screen under controlled vibratory motion, it separates particles by size, ensuring that only material within the specified particle size range proceeds to the next processing stage.
Sifting is performed at multiple points in a granulation line: before mixing to remove lumps and foreign matter from incoming raw materials; after wet granulation or milling to classify granule size; and before tablet compression or capsule filling to ensure blend uniformity. Each sifting stage directly contributes to content uniformity, blend flowability, and the overall quality of the final dosage form. The F Plus Sifter is engineered to deliver reliable, cGMP-compliant sifting performance across all these applications, with a contained, dust-tight design that protects both the product and the operator throughout the process.
Why Choose the F Plus Sifter ?
A contained, cGMP-compliant vibratory sifter engineered for accurate particle size classification and de-lumping at every stage of the pharmaceutical granulation process.
Looking to improve particle size consistency in your granulation line?
The F Plus Sifter is built for reliable, contained, cGMP-compliant sifting at every stage of the process.
Share your material type, particle size specification, throughput requirement, and line integration details with our team, and let’s identify the right sifter configuration for your application.
Frequently Asked Questions
Questions before you begin?
A pharmaceutical sifter classifies powders or granules by particle size and removes oversize agglomerates or foreign material before or after critical granulation stages.
It may be used before mixing to prepare raw materials, after granulation or drying to control size, or before downstream blending, compression, or capsule filling.
Consistent screening can improve powder flow, reduce oversized particles, protect downstream equipment, and support more uniform blending, die filling, and capsule dosing.
Yes. The inlet, outlet, transfer method, height, capacity, and containment interfaces can be configured for a new line or an existing production layout.
Selection depends on material characteristics, required particle-size range, throughput, batch size, screen area, upstream feed rate, and downstream process needs.
Yes. It is designed with pharmaceutical-grade product-contact construction, cleanability, and contained integration options suitable for cGMP-focused manufacturing.
